|
|
|
|
LEADER |
01940nam a2200373 a 4500 |
001 |
37259 |
003 |
BD-DhAAL |
008 |
210121t2018 enkacdo| |||| 001 0 eng d |
999 |
|
|
|c 41031
|d 41031
|
020 |
|
|
|a 9783319907543
|
040 |
|
|
|a BD-DhAAL
|
082 |
|
|
|a 615.19
|2 23
|
245 |
|
|
|a 3D Printing of Pharmaceuticals /
|c edited by Abdul W. Basit and Simon Gaisford.
|
246 |
|
|
|a Three D printing of pharmaceuticals
|
260 |
|
|
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2018.
|
300 |
|
|
|a xi, 240 pages :
|b color. illustrations ;
|c 24 cm.
|
490 |
|
|
|a AAPS Advances in the Pharmaceutical Sciences Series,
|v 31
|
504 |
|
|
|a Includes bibliographical references (pages 232-234) and index.
|
526 |
|
|
|a PHR
|
541 |
|
|
|a Hye Trade International
|e 37259, 37260, 37261
|
650 |
|
|
|a Medicine.
|9 40708
|
650 |
|
|
|a Pharmaceutical technology.
|9 40709
|
650 |
|
|
|a Biomedical engineering.
|9 40710
|
650 |
|
|
|a Biomedicine.
|9 40711
|
650 |
|
|
|a Pharmaceutical Sciences/Technology.
|9 40712
|
650 |
|
|
|a Biomedical Engineering/Biotechnology.
|9 40713
|
650 |
|
|
|a Pharmacy.
|9 43083
|
700 |
|
|
|a Basit, Abdul W.,
|e editor.
|9 40714
|
700 |
|
|
|a Gaisford, Simon,
|e editor.
|9 40715
|
852 |
|
|
|a Ayesha Abed Library
|c General Stacks
|
942 |
|
|
|2 ddc
|c BK
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_190000000000000_THR
|7 0
|9 68212
|a BRACUL
|b BRACUL
|c GEN
|d 2020-03-16
|e Hye Trade International
|g 11399.00
|l 0
|o 615.19 THR
|p 3010037261
|r 2020-03-16
|t 3
|v 11399.00
|w 2020-03-16
|y BK
|x Received during pandemic
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_190000000000000_THR
|7 0
|9 68213
|a BRACUL
|b BRACUL
|c GEN
|d 2020-03-16
|e Hye Trade International
|g 11399.00
|l 0
|o 615.19 THR
|p 3010037260
|r 2020-03-16
|t 2
|v 11399.00
|w 2020-03-16
|y BK
|x Received during pandemic
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_190000000000000_THR
|7 0
|9 68214
|a BRACUL
|b BRACUL
|c GEN
|d 2020-03-16
|e Hye Trade International
|g 11399.00
|l 0
|o 615.19 THR
|p 3010037259
|r 2020-03-16
|t 1
|v 11399.00
|w 2020-03-16
|y BK
|x Received during pandemic
|